Molecular genetics of colorectal cancer (Part 1)

Clinical Oncology

Volumn 9, Issue 1, 1997, Pages 14-19

  Wilson, R H ^a,c   Whiteside, M C R ^b   Russell, S E H ^b  

^a Northern Ireland Centre for Clinical Oncology   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; TELOMERASE;

BASE MISPAIRING; COLORECTAL CANCER; DISEASE PREDISPOSITION; DNA METHYLATION; HUMAN; MOLECULAR GENETICS; ONCOGENE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SHORT SURVEY; TUMOR SUPPRESSOR GENE;

EID: 0030991026     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0936-6555(97)80052-0     Document Type: Review

References (77)

1. Fearon ER, Hamilton SR, Vogelstein B. Clonal analysis of human colorectal tumours. Science 1987;238:193-7.
2. Nowell PC. Mechanisms of tumour progression. Cancer Res 1986;46:2203-7.
3. Dunlop MG. Allele loss and onco-suppressor genes. J Pathol 1991;163:1-5.
4. Bishop JM. The molecular genetics of cancer. Science 1987;235:305-11.
5. Knudson AG. Hereditary cancer, oncogenes and antioncogenes. Cancer Res 1985;45:1437-43.
6. Harris CC. Chemical and physical carcinogenesis: Advances and perspectives for the 1990s. Cancer Res 1991;51S:5023-44.
7. Eisenstein BI. The polymerase chain reaction. N Engl J Med 1990;322:178-83.
8. Onadim Z, Cowell JK. Application of PCR amplification of DNA from paraffin-embedded tissue sections to linkage analysis in familial retinoblastoma. J Med Genet 1991;28:312-6.
9. Krontiris TG. Oncogenes. N Engl J Med 1995;333:303-6.
10. Barbacid M. Ras genes. Annu Rev Biochem 1987;56:779-827.
11. McLennan EA, Owen RA, Stepniewska KA, et al. High frequency of K-ras mutations in sporadic colorectal adenomas. Gut 1993;34:392-6.
12. Studzinski GP, Brelvi ZS, Feldman SC, et al. Participation of c-myc protein in DNA synthesis of human cells. Science 1986;234:467-9.
13. Finley GG, Schulz NT, Hill SA, et al. Expression of the myc gene family in different stages of human colorectal cancer, Oncogene 1989;4:963-71.
14. Melhem MF, Meisler AI, Finley GG, et al. Distribution of cells expressing myc proteins in human colorectal epithelium, polyps and malignant tumors. Cancer Res 1992;52:5853-64.
15. Pena SY, Melhem MF, Meisler MI. Elevated c-yes tyrosine kinase activity in premalignant lesions of the colon. Gastroenterology 1995;108:117-24.
16. Cartwright CA, Meisler AI, Eckhart W. Activation of the p60 c-src protein kinase is an early event in colonic carcinogenesis. Proc Natl Acad Sci USA 1990;87:558-62.
17. Vogelstein B, Fearon ER, Scott EK, et al. Allelotype of colorectal carcinomas. Science 1989;2:207-11
18. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal tumour development. N Engl J Med 1988;319:525-32.
19. Bos JL, Fearon ER, Hamilton SR, et al. Prevalence of ras gene mutations in human colorectal cancers. Nature 1987;327:293-7.
20. Stanbridge EJ. Identifing tumour suppressor genes in human colorectal cancer. Science 1990;247:12-13.
21. Vogelstein B, Kinzler KW, The multistep nature of cancer. Trends Genet 1993;9:138-41.
22. Lane DP, Crawford LV. T antigen is bound to a host protein in SV40-transformed cells. Nature 1979;278:261-3.
23. Finlay CA, Hinds PW, Levine AJ. The p53 proto-oncogene can act as a suppressor of transformation. Cell 1989;57:1083-93.
24. Baker SJ, Markowitz S, Fearon ER, et al. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 1990;249:912-5.
25. Mowal MA, Cheng A, Kimura N, et al. Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by the Friend virus. Nature 1985;314:633-6.
26. Masuda H, Miller C, Koeffler HP, et al. Rearrangements of the p53 gene in human osteogeaic sarcomas. Proc Natl Acad Sci USA 1987;84:7716-9.
27. Baker SJ, Fearon ER, Nigro JM, et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 1989;244:217-21.
28. Baker SJ, Preisinger AC, Jessup JM, et al. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res 1990;50:7717-22.
29. Hollstein M, Sidransky D, Vogelstein B, et al. p53 mutations in human cancers. Science 1991;253:49-53.
30. Raycroft L, Wu H, Lozano Q. Transciptional activation by wild-type but not transforming mutants of the p53 antioncogene. Science 1990;249:1049-51.
31. Kern SE, Kinzler KW, Bruskin A, et al. Identification of p53 as a sequence-specific DNA-binding protein. Science 1991;252:1708-11.
32. Jenkins JR, Rudge K, Chumakov P, et al. The cellular oncogene p53 can he activated by mutagenesis. Nature 1985;317:816-8.
33. Cripps KJ, Purdie PJ, Carder PJ, et al. A study of stabilisation of p53 protein versus point mutation in colorectal carcinoma. Oncogene 1994;9:2739-43.
34. Bartek J, Bartkova J, Lukas J, et al. Immunohistochemical analysis of the p53 oncoprotein on parafin sections using a series of novel monoclonal antibodies. J Pathol 1993;169:27-34.
35. Hall PA, Lane DP. p53 in tumour pathology: Can we trust immunohistochemistry? - Revisited. J Pathol 1994;172:1-4.
36. Cunningham J, Lust JA, Schaid DJ, et al. Expression of p53 and 17p allelic loss in colorectal carcinoma. Cancer Res 1992;52:1974-80.
37. Vojtesek B, Fisher CJ, Barnes DM, et al. Comparison between p53 staining in tissue sections and p53 proteins measured by an ELISA technique. Br J Cancer 1993;67:1254-8.
38. Starzynska T, Bromley M, Ghosh A, et al. Prognostic significance of p53 overexpression in gastric and colorectal carcinoma. Br J Cancer 1992;66:558;62.
39. Purdie CA, Harrison DJ, Peters A, et al. Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. Oncogene 1994;9:603-9.
40. Lane DP. p53, guardian of the genome. Nature 1992;358:15-16.
41. Carson DA, Lois A. Cancer progression and p53. Lancet 1995;346:1009-11.
42. Clarke AR, Gledhill S, Hooper ML, et al. p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following γ-irradiation. Oncogene 1994;9:1767-73.
43. Shaw P, Bovey R, Tardy S, et al. Induction of apoptosis by wild type p53 in a human colon tumor-derived cell line. Proc Natl Acad Sci USA 1992;89:4495-9.
44. Watson AJM, Merritt AJ, Jones LS, et al. Evidence for reciprocity of bcl-2 and p53 expression in human colorectal adenomas and carcinomas. Br J Cancer 1996;73:889-95.
45. Bedi A, Pasricha PJ, Akhtar AJ, et al. Inhibition of apoptosis during development of colorectal cancer. Cancer Res 1995;55:1811-6.
46. Leppert M, Dobbs M, Scambler P, et al. The gene for familial polyposis coli maps to the long arm of chromosome 5. Science 1987;236:1411-3.
47. Bodmer WF, Baily CJ, Bodmer JET, et al. Localisation of the gene for familial adenomatous polypusis on chromosome 5. Nature 1987;328:614-6.
48. Rubinfield B, Souza B, Albert I, et al. Association of the APC gene product with beta-catenin. Science 1993;262:1731-4.
49. Thomas G. Advances in the genetics and molecular biology of colorectal tumors. Curr Opin Oncol 1994;6:406-12.
50. Powell SM, Zilz N, Beazer-Barclay Y, et al. APC mutations occur early during colorectal tumorigenesis. Nature 1992;359:235-7.
51. Olschwang S, Tiret E, Laurent-Puig P, et al. Restriction of ocular fundus lesions to a specific subgroup of APC mutations in adenomatous polyposis coli patients. Cell 1993;75:959-68.
52. Kinzler KW, Nilbert MC, Vogelstein B, et al. Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. Science 1991;251:1366-70.
53. Curtis LJ, Bubb VJ, Gledhill S, et al. Loss of heterozygosity of MCC is not associated with mutation of the retained allele in sporadic colorectal cancer. Hum Mol Genet 1994;3:443-6.
54. Fearon ER, Cho KR, Nigro JM, et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 1990;247:49-56.
55. Nigam AK, Savage FJ, Boulos PB, et al. Loss of cell-cell and cell-matrix adhesion molecules in colorectal cancer. Br J Cancer 1993;68:507-14.
56. Klingelhutz AJ, Hendrick JL, Cho KR, et al. The DCC gene suppresses the malignant phenotype of transformed human epithelial cells. Oncogene 1995;10:1581-6.
57. Peltomaki P, Aaltonen LA, Sistonen P, et al. Genetic mapping of a locus predisposing to human colorectal cancer. Science 1993;260:810-12.
58. Lindblom A, Tannergard P, et al. Genetic mapping of a second locus predisposing to hereditary nonpolyposis colon cancer. Nature Genet 1993;5:279-82.
59. Ionov Y, Peinado MA, Malkhoysan S, et al. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 1993;363:558-81.
60. Fishel R, Lescoe MK, Rao MRS, et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993;75:1027-38.
61. Leach FS, Nicolaides NC, Papadopoulos N, et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 1993;75:1215-25.
62. Bronner CE, Baker SM, Morrison PT, et al. Mutation in the DNA mismatch gene homologue hMLH1 is associated with hereditary nonpolyposis colon cancer. Nature 1994;368:258-61.
63. Nicolaides NC, Papadopoulos N, Liu B, et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994;371:75-80.
64. Peltomaki P. Microsatellite instability as an indicator of hereditary susceptibility to colon cancer. Gastroenterology 1995;109:2031-3.
65. Shibata D, Peinado MA, Ionov Y, et al. Genomic instability in repeated sequences is an early somatic event in colorectal tumorigenesis that persists after transformation. Nature Genet 1994;6:273-81.
66. Jacoby RF, Marshall, Kailas S, et al. Genetic instability associated with adenoma to carcinoma progression in hereditary nonpolyposis colon cancer. Gastroenterology 1995; 109:73-82.
67. Aaltonen LA, Peltomaki P, Leach FS, et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993;260:812-6.
68. Cawkwell L, Li D, Lewis FA, et al. Microsatellite instability in colorectal cancer: Improved assessment using fluorescent ploymerase chain reaction. Gastroenterology 1995;109:465-71.
69. Samowitz WS, Slattery ML, Kerber RA. Microsatellite instability in human colonic cancer is not a useful clinical indicator of familial colorectal cancer. Gastroenterology 1995;109:1765-71.
70. Aaltonen LA, Peltmaki P, Mecklin JP, et al. Replication errors in benign and malignant tumours from hereditary non-polyposis colorectal cancer patients. Cancer Res 1994;54:1645-8.
71. Young J, Leggett B, Gustafson C, et al. Genomic instability occurs in colorectal carcinomas but not in adenomas. Hum Mutat 1993;2:351-4.
72. Spruck CH, Rideout WM, Jones PA. DNA methylation and cancer. In; Jost JP, Saluz HPk, editors. DNA methylation: molecular biology and biological significance. Basic: Birkhauser Verlag, 1993:487-509.
73. Laird PW, Jaenisch R. DNA methylation and cancer. Hum Molec Genet 1994;3:1487-95.
74. Herman JG, Latif F, Weng Y, et al. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 1994;91:9700-704.
75. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-5.
76. Chadeneu C, Hay K, Hirte HW, et al. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res 1995;55:2533-6.
77. Wilson RH, Whiteside MCR, Russell SEH. Molecular genetics of colorectal cancer (Part 2). Clin Oncol. In press.